Skip to main content

Table 3 Ultrasonographic changes during the course of treatment

From: Sofosbuvir and daclatasvir are safe and effective in treatment of recurrent hepatitis C virus in Egyptian patients underwent living donor liver transplantation

Item Frequency Percentage
US before treatment
 Splenomegaly 6 155
 Normal 24 85
US 1 month after starting treatment
 HFL 0 0
 No HFL 40 100
US after the end of treatment
 HFL 0 0
 No HFL 40 100
US 3 months after the end of treatment
 HFL 0 0
 No HFL 40 100
US 6 months after the end of treatment
 HFL 0 0
 No HFL 40 100
US 9 months after the end of treatment
 HFL 0 0
 No HFL 40 100
  1. HFL hepatic focal lesion